GPC sobre Trastornos de Conducta Alimentaria (TCA)

321. Leitenberg H, Rosen JC, Wolf J, Vara LS, Detzer MJ, Srebnik D. Comparison of cognitive-behavior
therapy and desipramine in the treatment of bulimia nervosa. Behav Res Ther.
1994;32(1):37-45.
322. Cognitive-behavioral, fluoxetine and combined treatment for bulimia nervosa: short-andlong-term
results. Eur Eat Disord Rev. 2002;10:179-98.
323. Goldbloom DS, Olmsted M, Davis R, Clewes J, Heinmaa M, Rockert W, et al. A randomized
controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: short-term
outcome. Behav Res Ther. 1997;35(9):803-11.
324. Agras WS, Rossiter EM, Arnow B, Schneider JA, Telch CF, Raeburn SD, et al. Pharmacologic
and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison. Am J
Psychiatry. 1992;149(1):82-7.
325. Agras WS, Rossiter EM, Arnow B, Telch CF, Raeburn SD, Bruce B, et al. One-year follow-up
of psychosocial and pharmacologic treatments for bulimia nervosa. J Clin Psychiatry.
1994;55(5):179-83.
326. Wilson GT, Loeb KL, Walsh BT, Labouvie E, Petkova E, Liu X, et al. Psychological versus
pharmacological treatments of bulimia nervosa: predictors and processes of change. J Consult
Clin Psychol. 1999;67(4):451-9.
327. Mitchell JE, Halmi K, Wilson GT, Agras WS, Kraemer H, Crow S. A randomized secondary
treatment study of women with bulimia nervosa who fail to respond to CBT. Int J Eat Disord.
2002;32(3):271-81.
328. Walsh BT, Fairburn CG, Mickley D, Sysko R, Parides MK. Treatment of bulimia nervosa in a
primary care setting. Am J Psychiatry. 2004;161(3):556-61.
329. Grilo CM, Masheb RM, Wilson GT. Efficacy of cognitive behavioral therapy and fluoxetine
for the treatment of binge eating disorder: a randomized double-blind placebo-controlled
comparison. Biol Psychiatry. 2005;57(3):301-9.
330. Grilo CM, Masheb RM, Salant SL. Cognitive behavioral therapy guided self-help and orlistat
for the treatment of binge eating disorder: a randomized, double-blind, placebo-controlled
trial. Biol Psychiatry. 2005;57(10):1193-201.
331. Devlin MJ, Goldfein JA, Petkova E, Liu L, Walsh BT. Cognitive behavioral therapy and fluoxetine
for binge eating disorder: two-year follow-up. Obesity (Silver Spring). 2007;15(7):1702-9.
332. Fairburn CG, Peveler RC, Jones R, Hope RA, Doll HA. Predictors of 12- month outcome in
bulimia nervosa and the influence of attitudes to shape and weight. J Consult Clin Psychol.
1993;61(4):696-8.
333. Crow SJ, Agras WS, Crosby R, Halmi K, Mitchell JE. Eating disorder symptoms in pregnancy:
a prospective study. Int J Eat Disord. 2008;41(3):277-9.
334. Franko DL, Walton BE. Pregnancy and eating disorders: a review and clinical implications.
Int J Eat Disord. 1993;13(1):41-7.
335. Fairburn C, Welch S. The impact of pregnancy on eating habits and attitudes to shape and
weight. Int J Eat Disord. 1990;9(2):153-60.
336. Brinch M, Isager T, Tolstrup K. Patient's evaluation of their former treatment for anorexia
nervosa. Nordisk Psykiatrisk Tidsskrift. 1988;42:445-8.
337. Bulik CM, Sullivan PF, Fear JL, Pickering A, Dawn A, McCullin M. Fertility and reproduction
in women with anorexia nervosa: A controlled study. J Clin Psychiatry. 2008;60:130-5.
338. Treasure JL, Russell GF. Intrauterine growth and neonatal weight gain in babies of women
with anorexia nervosa. Br Med J (Clin Res Ed). 1988;296(6628):1038.
339. Russell GF, Treasure J, Eisler I. Mothers with anorexia nervosa who underfeed their children:
their recognition and management. Psychol Med. 1998;28(1):93-108.
340. Wezel-Meijler G, Wit JM. The offspring of mothers with anorexia nervosa: a high-risk group
for undernutrition and stunting? Eur J Pediatr. 1989;149:130-5.
GUÍA DE PRÁCTICA CLÍNICA SOBRE TRASTORNOS DE LA CONDUCTA ALIMENTARIA 291